Mhd Iyad Al Shwaf, MD
Rheumatology · Lansing, MINPI 1801399365
Payments from drug & device makers
Across 1,458 payments — averaging $16.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$5K
- Amgen$4K
- AbbVie$3K
- UCB, Inc.$2K
- Novartis$1K
- AstraZeneca$1K
- plus $7K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 471 | $5,244 |
| Amgen(2 entities) | 192 | $4,082 |
| AbbVie | 227 | $3,328 |
| UCB, Inc. | 77 | $1,778 |
| Novartis | 76 | $1,374 |
| AstraZeneca(2 entities) | 50 | $1,134 |
| E.r. Squibb & Sons, L.L.C. | 84 | $1,106 |
| Pfizer | 58 | $682 |
| Boehringer Ingelheim | 22 | $594 |
| Lilly USA, LLC | 27 | $495 |
| Mallinckrodt Hospital Products Inc. | 23 | $476 |
| GSK | 23 | $400 |
| Organon | 20 | $393 |
| ANI Pharmaceuticals, Inc. | 18 | $355 |
| Genentech USA, Inc. | 12 | $351 |
| Aurinia Pharma U.S., Inc. | 10 | $329 |
| United Therapeutics Corporation | 2 | $229 |
| Regeneron Healthcare Solutions, Inc. | 9 | $187 |
| Sobi, Inc | 7 | $134 |
| Radius Health, Inc. | 7 | $129 |
| Sandoz | 5 | $107 |
| Sanofi | 5 | $100 |
| Alvogen Inc | 5 | $90 |
| Fresenius Kabi USA, LLC | 4 | $89 |
| Mallinckrodt Enterprises LLC | 4 | $79 |
| Actelion Pharmaceuticals US, Inc. | 4 | $57 |
| Janssen Scientific Affairs, LLC | 2 | $54 |
| Daiichi Sankyo Inc. | 3 | $53 |
| Merck | 2 | $49 |
| Bioventus LLC | 3 | $42 |
| Alnylam Pharmaceuticals Inc. | 2 | $37 |
| Boston Scientific | 1 | $25 |
| Tersera Therapeutics LLC | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $16 |
How this compares
$23,638 in reported general payments places this provider in the 75th percentile of 195 rheumatology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Lansing
- Joshua JuneLansing$2.3M
- Carol BealsLansing$29K
- Dinesh KhannaAnn Arbor$28M
- Amar MajjhooSaint Clair Shores$9.1M
- Joanne KahlenbergAnn Arbor$6M
- Andrew SulichSaint Clair Shores$3.4M
- Elena SchiopuAnn Arbor$3M
- Ali KarrarGrand Blanc$2.5M
- Monika MohanOkemos$1.6M
- Kathleen Maksimowicz McKinnonDetroit$842K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.